GE HealthCare to showcase comprehensive cardiology portfolio at ACC.26, including its latest AI-enabled imaging technologies, advanced software solutions, and key collaborations

• The company will highlight the newly U.S. FDA 510(k) cleared Photonova Spectra photon-counting CT system, ReadyFix fleet management solution enabled to work with MAC VU360 resting ECG workstations, and a new collaboration to advance interventional cardiology

CHICAGO--(BUSINESS WIRE)--At ACC.26, GE HealthCare (Nasdaq: GEHC) will showcase some of its boldest ideas yet that support clinicians across the cardiology care pathway - from diagnosis to treatment to procedural guidance and monitoring. Its latest cardiology innovations, featuring advancements within diagnostic cardiology, CT, image guiding solutions, ultrasound, cloud, and software solutions, are helping clinicians deliver critical precision care throughout the patient journey.

According to the American Heart Association, cardiovascular disease remains the leading cause of death in the United States, with one person dying every 34 seconds and more than 900,000 lives lost each year. As patient volumes rise and nearly half of U.S. adults live with some form of cardiovascular diseaseⁱ, clinicians face increasing pressure to detect disease earlier, characterize it more precisely and make confident decisions faster — often with limited time and resources. The solutions GE HealthCare will feature at ACC.26 are designed to help address these demands through ultra‑high‑definition imaging, advanced intravascular visualization, and AI‑supported workflows.

Photon‑counting CT: A new era for cardiac imaging

GE HealthCare will highlight continued advancement in photon‑counting CT with the newly U.S. FDA 510(k) cleared Photonova™ Spectra, an AI‑enabled imaging system, powered by proprietary Deep Silicon detectors. Photon‑counting CT directly measures individual X‑ray photons and their energy, enabling ultra‑high‑definition imaging, improved tissue characterization and enhanced material differentiation. For cardiology, this advancement is designed to support more detailed visualization of coronary anatomy, plaque characterization and dose‑conscious cardiac imaging — with the aim of helping clinicians gain greater diagnostic confidence.

“The cardiology field is entering a new era where imaging quality, data intelligence and workflow efficiency must come together seamlessly,” said Eigil Samset, General Manager, Cardiology Solutions at GE HealthCare. “At ACC.26, we’re showing how innovations like Deep Silicon photon‑counting CT and advanced intravascular imaging can help clinicians see clearly, act confidently and deliver truly personalized heart care across every stage of the patient journey.”

Introducing ReadyFix to help advance operational efficiency and reliability in cardiac care

For the first time at a U.S. cardiology event, GE HealthCare will showcase ReadyFix™ fleet management solutionⁱⁱ enabled to work with MAC VU360™ resting electrocardiodiagram (ECG) workstations. Recently launched in the U.S., ReadyFix works with MAC VU360 to help optimize cardiac care delivery and device uptime through access to real-timeⁱⁱⁱ data and remote software deployment configuration management and diagnostics. ReadyFix can help health systems proactively maintain and optimize MAC VU360 performance, remotely from a centralized dashboard, to reduce device-related disruptions — supporting care teams in providing consistent, quality care for patients.

GE HealthCare strengthens its vision for the cath lab with new collaboration and innovative technology

At ACC.26, GE HealthCare will highlight how it continues to advance its offerings for the cardiac catheterization lab through intelligent imaging, workflow-focused interventional solutions, and collaborations designed to broaden access to complementary technologies. This includes its recent agreement with Gentuity in the U.S., which will seamlessly connect GE HealthCare customers with Gentuity HF-OCT and Vis-Rx® PRIME Micro-Imaging Catheter. Together, these technologies are designed to support percutaneous coronary intervention planning, and enhanced intraprocedural visualization in complex coronary procedures. This news builds on recent momentum across GE HealthCare’s interventional portfolio, including the recent U.S. FDA 510(k) clearance and CE Mark for Allia Moveo, the latest Allia IGS platform designed to assist clinicians across a wide range of interventional procedures.

“Our focus is on helping clinicians navigate complexity in the cath lab with greater confidence,” said Philip Rackliffe, President and CEO, Advanced Visualization Solutions at GE HealthCare. “Our collaboration with Gentuity is an important example of how we are expanding access to advanced imaging technologies—and empowering clinicians to make critical decisions with greater clarity and precision—while continuing to build on our broader interventional portfolio.”

To learn more about GE HealthCare’s cardiology innovations, please visit this website or engage onsite at ACC.26 at booth #1726. The booth experience includes a guided “Story of the Heart” tour, bringing to life how GE HealthCare supports clinicians across the coronary artery disease care continuum — from triage and diagnosis to procedural guidance.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

^i American Heart Association. (2025). Heart disease and stroke statistics—2025 update: A report from the American Heart Association. Circulation, 151, e41–e660. https://doi.org/10.1161/CIR.0000000000001303

^ii Use of ReadyFix is limited to ReadyFix-enabled devices. MAC VU360 software version 3.0 is required.

^iii Actual time may vary slightly due to hospital network and processing times.